NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/22/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization12.79 mln
Float0.82 mln
Earnings Date05/07/2026
EPS
1,214
Exceptional
P / E
0.01
Anomalous
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
30.00
Transformational upside
Relative Strength
99
/ 100
Top performer
Debt / Equity
0.20
Very low leverage
Business Description
Ernexa Therapeutics Inc. is a Cambridge, Massachusetts-based company founded in 2018 that creates stem cell-based treatments for cancer and autoimmune conditions. Its two lead programs use specially engineered stem cells to either attack tumors in ovarian cancer or calm harmful immune responses in rheumatoid arthritis. The company, formerly known as Eterna Therapeutics Inc., operates under a licensing agreement with Factor Bioscience Limited and changed its name in March 2025.
